Ulcerative Colitis (M14-234)

The purpose of the study is to evaluate the safety and efficacy of ABT-494 for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis.

Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.

Source: www.MayoClinic.org

https://clinicaltrials.gov/ct2/show/NCT03006068?term=M14-234&rank=1

Register Today!

Let others know about this Trial!

Trial Information

StatusIn Recruitment
Start DateSeptember 2016
End DateTBD
Trial DurationUp to 61 weeks
Number of Visits8-18 Varies Depending
on Sub-study eligibility
Lead CRCSuzanne Fleming

For additional information
on this trial contact:

Phone705-566-0005